ClinicalTrials.Veeva

Menu

The Effect of New-style Vaginal Repair Mesh in the Treatment of Female Stress Urinary Incontinence

J

Jinan Military General Hospital

Status

Unknown

Conditions

Stress Urinary Incontinence

Treatments

Device: Mesh

Study type

Interventional

Funder types

Other

Identifiers

NCT02934490
2013ZX05

Details and patient eligibility

About

The study is to explore the effectiveness of a new-style anterior vaginal wall mesh in the treatment of female stress urinary incontinence(SUI). Meshes were made by Gynemech TM PS, (Johnson & Johnson Shanghai Medical Equipment Co. China Food and Drug Administration (CFDA) registration No. 3460365, size 10 × 15cm). Meshes were cut to appropriate size. The incontinence questionnaire summary table (ICIQ-SF), pad test, urodynamic and other diagnostic tests were used for preoperative assessment and the evaluation of postoperative surgical outcome and complication. The results were compared with the one-year cure rates of Burch and trans vaginal taping (TVT) surgeries. The analysis indicated that the surgery using the new-style anterior vaginal mesh, as a minimally invasive procedure, not only achieved its expectation with similar cure rate to Burch, TVT/ trans vaginal taping obturator (TVT-O) surgeries, but also has lower economic cost and complication rate than the TVT /TVT-O approach. The evaluation of long-term treatment effect needs further follow-up of the patients.

Enrollment

316 estimated patients

Sex

Female

Ages

27 to 82 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with clinically and biopsy confirmed non-neoplastic lesions of genital skin and mucous membrane (non-neoplasia epithelial disorders of skin and mucosa of vulva). Symptoms include repeated itching, discoloration, rhagades, loss of skin elasticity and dyspareunia that affect the patients' quality of life.

Exclusion criteria

  • Atypical hyperplasia or vulvar cancer confirmed by biopsy of genital lesions;
  • Vulvovaginal or other gynecological trauma, acute inflammatory diseases and other acute illness in need of urgent care;
  • Combined with other serious gynecological diseases (symptomatic hysteromyoma, ovarian tumor, etc.), and/or severe organ diseases (such as heart, lung, brain and renal disease/failure) that need immediate treatment;
  • Other type of cancers that require urgent care.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

316 participants in 1 patient group

Treatment group
Experimental group
Treatment:
Device: Mesh

Trial contacts and locations

1

Loading...

Central trial contact

Geping Yin, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems